MMJ Recs

DECEMBER 13, 2023

Let’s take a look at the current state of medical marijuana dispensaries in Texas, examining the legal framework, patient access, and the potential impact on the healthcare landscape. Qualifying conditions include epilepsy, terminal cancer, multiple sclerosis, autism, and incurable neurodegenerative diseases.

Dispensary 52

Dispensary Patients Marijuana Epilepsy 52

Veriheal

OCTOBER 19, 2022

Warastuti, the mother of Pika Sasi Kirana, is actively lobbying for legal access and research into the plant alongside her daughter’s father, Sunarta. Even after being prescribed epilepsy medication, her condition continued to deteriorate. “No Mothers Push for Cannabis Access in Indonesia. Sadly, the child lost his life.

Legalization 104

Legalization Research and Development Chronic Pain Treatment 104

Cannabis Law Report

JANUARY 13, 2020

12, 2020 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, today reported preliminary, unaudited net product sales for the fourth quarter and full-year 2019 and key priorities for 2020. 14th at 11:00 a.m. PT (2:00 p.m.

Pharmaceutical 66

Pharmaceutical Clinical Trials Research and Development Programs 66

Cannabis Law Report

JUNE 5, 2019

30 May 2019. The Pharmaceutical Organization, Department of Medical Affairs, signed a joint research on standard quality medical marijuana extracts for patients with chemo-allergic cancer, epilepsy, muscle contraction in patients with deteriorating nerve sheaths. Effective, most effective in treatment Relieve symptoms.

Pharmaceutical 40

Pharmaceutical Extraction Epilepsy Research and Development 40

Cannabis Law Report

NOVEMBER 2, 2021

Anvisa approved the regulation of cannabis-based products in December 2019 and until now it had only authorized the use of three other medicines with this active principle in the country.

Medicine 52

Medicine Chronic Pain Epilepsy Marijuana 52

Peninsula Alternative Health

MAY 15, 2019

Epilepsy Seizure disorders are on the list of qualifying conditions for most medical cannabis states. Because nearly one-third of patients with epilepsy are not getting the results they want from conventional treatments, they are eager to experiment with natural cannabinoid therapy. tetrahydrocannabinol (THC).

Conditions 89

Conditions Therapy Cannabinoids Epilepsy 89

The Cannigma

SEPTEMBER 28, 2021

In 2019, Ireland’s Minister for Health signed legislation to allow a pilot plan for medical cannabis, which launched in 2021 and is set to run for five years. Along with Sativex, the cannabis-based medicine Epidylolex is approved for use with specific conditions like severe forms of pediatric epilepsy and can be prescribed by a physician.

Law 61

Law Marijuana Treatment Epilepsy 61

The Cannigma

SEPTEMBER 28, 2021

In 2019, Ireland’s Minister for Health signed legislation to allow a pilot plan for medical cannabis, which launched in 2021 and is set to run for five years. Along with Sativex, the cannabis-based medicine Epidylolex is approved for use with specific conditions like severe forms of pediatric epilepsy and can be prescribed by a physician.

Law 60

Law Marijuana Treatment Epilepsy 60

MMJ Recs

NOVEMBER 11, 2020

This question is being asked by patients all over the world who would see a massive benefit in their quality of life if they could avail of medical marijuana treatment. Medical marijuana is now proven beyond doubt to be a very effective treatment for a whole host of painful and debilitating conditions.

Legalization 52

Legalization Decriminalization Marijuana Epilepsy 52

The Cannigma

JULY 5, 2022

In-state cultivation and distribution weren’t legalized until 2019. Insurance is not required to cover cannabis treatments when the products are legal, so the cost of the program is unknown. The only way to access the plant and its products is through the legacy market (aka the black market). Possible penalties.

Law 96

Law Decriminalization Programs Patients 96

CannaTech

JUNE 30, 2019

These include changes to reduce barriers to patient access, specific licensing requirements for production, and expanding the number of access points approved of sale. Patients over the age of 18 (excepting children with severe epilepsy). Neurological indications such as epilepsy, Parkinson’s.

Patients 90

Patients Oil Epilepsy Strains 90

Cannabis Law Report

JANUARY 15, 2020

million Series A funding round in 2019, Cannaray has announced the fulfilment of its first UK patient prescription as the company continues to grow, becoming one of UK’s largest Medical Cannabis and CBD company. . Following a £7.8 Cannaray today announces the fulfilment of its first Medical Cannabis prescription in the UK.

CBD 64

CBD Epilepsy Chronic Pain Treatment 64

Veriheal

SEPTEMBER 15, 2023

In April 2019, House Bill 324 was approved, enabling in-state cultivation and the sale of low-THC oil. The medical conditions that qualify for this program typically include severe and debilitating conditions like epilepsy, cancer, multiple sclerosis, and Parkinson’s disease, among others.

Programs 62

Programs Legalization Oil Conditions 62

Cannabis Law Report

MAY 31, 2021

Unfortunately, this was blocked by the Senate in 2019 when Duterte changed his tune and declared the opposite in a campaign rally in Negros Occidental. This probably inspired the approval on the third and final reading of House Bill (HB) No. 6517 (Philippine Compassionate Medical Cannabis Act).

Seed-To-Sale 66

Seed-To-Sale Epilepsy Medicine Sativa 66

MMJ Recs

FEBRUARY 9, 2022

The state opened its first dispensary in August 2019. So that more people can gain access to the treatment, the Louisiana MMJ program continues to expand, with more qualifying conditions added to the list as well as more cannabis included under the MMJ umbrella. When applying online, make sure that the service is legitimate.

Marijuana 52

Marijuana Conditions Access Chronic Pain 52

Cannabis Law Report

SEPTEMBER 24, 2019

T he EU has approved for the first time the use of a medicinal cannabis product aimed at patients with two rare, but severe, forms of childhood epilepsy. The medication, developed by GW Pharmaceuticals, will be used in combination with another epilepsy medication called clobazam. September 23, 2019. What do experts say?

Pharmaceutical 55

Pharmaceutical Epilepsy Research and Development Medicine 55

Veriheal

JANUARY 15, 2021

So does that mean that there is no access to THC for patients in the country? The Medical Cannabis Access Programme. In 2019 Ireland’s Health Minister Simon Harris signed legislation known as the Misuse of Drugs, Prescriptions, and Control of Supply of Cannabis for Medical Use Regulations 2019. Not exactly.

Legalization 57

Legalization Therapy Access Legislation 57

Veriheal

MAY 31, 2022

opioid epidemic, which claimed a record number of lives in 2021 , is the result of America’s faulty regulation of these powerful pain-killing drugs and a widespread lack of access to safe and adequate pain management solutions. A 2019 study found that 76% of patients in the U.S. The Opioid Problem.

Programs 52

Programs Chronic Pain Treatment Conditions 52

MMJ Recs

DECEMBER 5, 2021

This allowed NY residents who needed MMJ to access it safely, within limitations. It was officially decriminalized in 2019 , and as of March 2021, has become legal for adult recreational use as well as medical use. This guarantees you access to the wide variety of MMJ products available for sale at the state’s dispensaries.

Marijuana 59

Marijuana Dispensary Chronic Pain Access 59

The Cannigma

OCTOBER 20, 2021

Furthermore, in 2017 the Norwegian parliament voted in favor of a measure to decriminalize drug use, shifting the focus of drug policies towards treatment. Norway has an official medical cannabis system, but its access is extremely limited and prescriptions are difficult to obtain (Wikimedia). In addition, 29.2% In addition, 29.2%

Legalization 59

Legalization Decriminalization Patients Medicine 59

Veriheal

SEPTEMBER 2, 2022

Individuals in the country with conditions such as Parkinson’s disease, depression, insomnia, ADHD, multiple sclerosis, anxiety, chronic pain, and epilepsy have embraced the option of medical cannabis. estimates that 60-70% of his patients are seeking out medical cannabis for the treatment of chronic pain.

Chronic Pain 57

Chronic Pain Patients Decriminalization Cannabis 57

The Cannigma

AUGUST 26, 2021

The country legalized medical cannabis in 2016, but patients in the country have long criticized the program as too restrictive, and access to cannabis-based medicines remains behind that of many other legal cannabis jurisdictions. This also means that the TGA has not accessed these medicines for their safety, quality, or effectiveness.

Legalization 52

Legalization Access Medicine Clinical Trials 52

Cannabis Law Report

AUGUST 21, 2019

Cannabis treatments are too expensive and do not come with enough test evidence to be effective, UK authorities have said. It also said current treatments for adults suffering severe symptoms were “not cost effective”. The Trust is encouraging responses to the guideline which can be sent via the NICE website by 5pm on 5 September 2019.

Clinical Trials 81

Clinical Trials Nerve Pain Medicine Epilepsy 81

Cannabis Law Report

DECEMBER 9, 2019

Although official uses (outside of treatment for childhood epilepsy) have not been officially approved by the FDA, early results from research has resulted in consumers flocking to the compound of their own accord and at their own risk. Anxiety and Inflammation Lead the Pack. CBD items for pets are being developed at breakneck pace.

Pets 59

Pets CBD Research and Development Epilepsy 59

The Cannigma

JUNE 15, 2021

The first clinical research done on CBD as a potential treatment for epilepsy was in 1980, but the information gleaned didn’t make its way to the public eye until decades later. CBG, however, also has some medicinal potential that CBD doesn’t, for instance as a treatment for hypertension and insulin resistance. Shutterstock).

CBD 122

CBD Research and Development Epilepsy Extraction 122

CannaMD

SEPTEMBER 15, 2020

SHORT ANSWER: In November 2016, the Florida Medical Marijuana Legalization Initiative (known as Amendment 2 ) legalized medical marijuana treatment in Florida. Patients suffering from cancer, epilepsy, chronic seizures, or muscle spasms could use low-THC cannabis products recommended by a licensed doctor. Qualified patient.

Law 126

Law Marijuana Patients Treatment 126

Veriheal

OCTOBER 1, 2020

Cannabis is easily accessible, and the regulations are loosening up quite a bit. The media storm came about as 12-year-old Billy Caldwell and 6-year-old Alfie Dingley were being denied cannabis oil as a treatment for their epilepsy. It proposes that cannabis can strictly be accessed by prescription alone. .

Legalization 104

Legalization Oil Medicine Media 104

Cannabis Law Report

NOVEMBER 22, 2019

In Brazil, the initial step to allow the use of cannabis sativa for medical purposes was taken in 2014, when the Judiciary granted the first injunction to authorize a patient to import and use cannabidiol-rich oil (CBD) for the refractory epilepsy treatment. plant or substances obtained from it in its composition. Source: [link].

Sativa 59

Sativa Medicine Legalization Epilepsy 59

MassRoots

JULY 30, 2020

Initiatives 65 and 65A would amend Mississippi’s state constitution to allow patients with certain qualifying conditions to access medical marijuana after having been approved by a licensed physician. Patients would be allowed to possess 2.5 ounces at a time, and would be prohibited from smoking cannabis in public spaces.

Marijuana 84

Marijuana Conditions Epilepsy Patients 84

The Cannigma

OCTOBER 8, 2021

The United Kingdom legalized medical cannabis in November 2018 but the program is the subject of criticism regarding access to medicine and approval of patients. This follows a report from 2019 that found that around 500 people are caught with cannabis by Scottish police each month and are released with a warning.

Legalization 52

Legalization Medicine Conditions Patients 52

Veriheal

NOVEMBER 20, 2020

While Oregon became the first state to decriminalize all drugs , this election cycle also saw five other states passing legislation that will ultimately make cannabis more accessible to their citizens.

Legalization 98

Legalization Epilepsy Cannabis Legislation 98

Cannabis Law Report

NOVEMBER 22, 2019

Medical cannabis users in Massachusetts are on track to regain access to vaping products starting Tuesday, November 12, after the Cannabis Control Commission did not uphold the Baker administration’s ban, though that permission could be short-lived amid ongoing legal challenges and potential future regulations from the commission.

Vaping 45

Vaping Research and Development Seed-To-Sale Hemp 45

SpeedWeed

APRIL 29, 2021

As of now, only patients with terminal cancer, intractable epilepsy, seizures, multiple sclerosis, spasticity, amyotrophic lateral sclerosis, autism, and other neurodivergent issues are covered. percent to 5 percent, meaning that patients in Texas would now actually be able to access medicine with THC. HB 1535 would change all of this.

Programs 52

Programs Chronic Pain Access Patients 52

Peninsula Alternative Health

MAY 15, 2019

Epilepsy Seizure disorders are on the list of qualifying conditions for most medical cannabis states. Because nearly one-third of patients with epilepsy are not getting the results they want from conventional treatments, they are eager to experiment with natural cannabinoid therapy. tetrahydrocannabinol (THC).

Conditions 40

Conditions Therapy Cannabinoids Epilepsy 40

MMJ Recs

SEPTEMBER 15, 2021

The state issued its first MMJ business licenses in late 2019, but the Missouri MMJ program was a little slow to get off the ground. A group called Fair Access Missouri has filed a series of potential petitions to legalize recreational MMJ in the state. Who Can Access Missouri Medical Marijuana Dispensaries?

Recreational 52

Recreational Dispensary Conditions Access 52

Cannabis Law Report

JUNE 26, 2019

Minister for Health Simon Harris TD today signed legislation which will allow for the operation of the Medical Cannabis Access Programme on a pilot basis for five years. The Programme will facilitate access to cannabis-based products for medical use in line with legislation. We have highlighted relevant passages.

Medicine 55

Medicine Access Business Legislation 55

CannaTech

SEPTEMBER 23, 2019

The acceptance of medical cannabis by clinicians, researchers and government bodies is fairly universal, and patients have benefited from widespread access to full-spectrum cannabis in flower and oil form. Israel’s approach to cannabis has contributed to reducing stigma and increasing access for patients around the world.

Patients 79

Patients Policy Clinical Trials Research and Development 79